JS']JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1

被引：33

作者：

Asahina, Yasuhiro ^{[1
]}

Hayashi, Norio ^{[2
]}

Hiramatsu, Naoki ^{[3
]}

Izumi, Namiki ^{[4
]}

Koike, Kazuhiko ^{[5
]}

Kumada, Hiromitsu ^{[6
]}

Kurosaki, Masayuki ^{[4
]}

Oketani, Makoto ^{[7
]}

Suzuki, Fumitaka ^{[6
]}

Takikawa, Hajime ^{[8
]}

Tanaka, Atsushi ^{[8
]}

Tanaka, Eiji ^{[9
]}

Tanaka, Yasuhito ^{[10
]}

Tsubouchi, Hirohito ^{[11
]}

Yotsuyanagi, Hiroshi ^{[12
]}

机构：

[1] Tokyo Med & Dent Univ, Dept Hepatitis Control, Dept Gastroenterol & Hepatol, Tokyo, Japan

[2] Kansai Rosai Hosp, Inabasou, Amagasaki Shi, Japan

[3] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 565, Japan

[4] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Musashino, Tokyo, Japan

[5] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138654, Japan

[6] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan

[7] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan

[8] Teikyo Univ, Sch Med, Dept Med, Tokyo 1738605, Japan

[9] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano, Japan

[10] Nagoya City Univ, Sch Med, Grad Sch Sci, Dept Clin Mol Informat Med, Nagoya, Aichi, Japan

[11] Kagoshima City Hosp, Kagoshima, Japan

[12] Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138654, Japan

来源：

HEPATOLOGY RESEARCH | 2014年 / 44卷

关键词：

SIMEPREVIR TMC435; IN-VITRO; PROTEASE; PEGINTERFERON/RIBAVIRIN; INTERFERON; INHIBITOR; RIBAVIRIN; THERAPY; PROFILE;

D O I：

10.1111/hepr.12272

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：59 / 70

页数：12

共 18 条

[1] The exploration of macrocycles for drug discovery - an underexploited structural class [J].

Driggers, Edward M. ;

Hale, Stephen P. ;

Lee, Jinbo ;

Terrett, Nicholas K. .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (07) :608-624

[2]

Editors of the Drafting Committee for Hepatitis Management Guidelines: the Japan Society of H, 2013, HEPATOL RES, V43, P1

[3] Once-Daily Simeprevir (TMC435) With Pegylated Interferon and Ribavirin in Treatment-Naive Genotype 1 Hepatitis C: The Randomized PILLAR Study [J].

Fried, Michael W. ;

Buti, Maria ;

Dore, Gregory J. ;

Flisiak, Robert ;

Ferenci, Peter ;

Jacobson, Ira ;

Marcellin, Patrick ;

Manns, Michael ;

Nikitin, Igor ;

Poordad, Fred ;

Sherman, Morris ;

Zeuzem, Stefan ;

Scott, Jane ;

Gilles, Leen ;

Lenz, Oliver ;

Peeters, Monika ;

Sekar, Vanitha ;

De Smedt, Goedele ;

Beumont-Mauviel, Maria .

HEPATOLOGY, 2013, 58 (06) :1918-1929

[4] A pilot study of triple therapy with telaprevir, peginterferon and ribavirin for elderly patients with genotype 1 chronic hepatitis C [J].

Hara, Tasuku ;

Akuta, Norio ;

Suzuki, Fumitaka ;

Sezaki, Hitomi ;

Suzuki, Yoshiyuki ;

Hosaka, Tetsuya ;

Kobayashi, Masahiro ;

Kobayashi, Mariko ;

Saitoh, Satoshi ;

Kumada, Hiromitsu .

JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (10) :1746-1753

[5]

Hayashi N, 2013, KANZO, V54, pA24

[6] Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1-infected patients in Japan: the DRAGON study [J].

Hayashi, Norio ;

Seto, Chiharu ;

Kato, Mai ;

Komada, Yuji ;

Goto, Shoichiro .

JOURNAL OF GASTROENTEROLOGY, 2014, 49 (01) :138-147

[7]

Huisman MT, 2010, HEPATOLOGY, V52, p461A

[8]

Izumi N, 2013, KANZO, V54, pA156

[9] SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAIVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL [J].

Jacobson, I. ;

Dore, G. J. ;

Foster, G. R. ;

Fried, M. W. ;

Radu, M. ;

Rafalskiy, V. V. ;

Moroz, L. ;

Craxi, A. ;

Peeters, M. ;

Lenz, O. ;

Ouwerkerk-Mahadevan, S. ;

Kalmeijer, R. ;

Beumont-Mauviel, M. .

JOURNAL OF HEPATOLOGY, 2013, 58 :S574-S574

[10]

Lawitz E, 2013, GASTROENTEROLOGY, V144, pS151

← 1 2 →